REZUROCK

Identification of Rezurock

No description

Google image searchProduct monograph

Active ingredient

belumosudil (belumosudil mesylate), 200 MG

DIN: 02526115

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: SANOFI-AVENTIS CANADA INC

Date: 08-MAR-2023

ATC:

• L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
• L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
• L04AA — Selective immunosuppressants (ATC, ATC/DDD)
• L04AA48 — BELUMOSUDIL (ATC/DDD)

External Links for Rezurock

Search on Google

• Rezurock side effects
• Rezurock dosage
• belumosudil side effects
• belumosudil dosage

Sanofi-Aventis Canada Inc

Go to Sanofi-Aventis website to see drug product details. Sometimes you can find rezurock photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.